Merck ends development of Parkinson's disease drug preladenant based on study results

  • by: Associated Press
  • Updated: May 23, 2013 - 4:31 PM

WHITEHOUSE STATION, N.J. - Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

  • 0
  • Comments

There are currently no comments for this article

Comment on this story   |   Be the first to comment

Be the first to comment

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT